{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:07:01Z","timestamp":1789927621346,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012304","name":"School of Medicine, Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014804","name":"Neurofibromatosis Therapeutic Acceleration Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jid.2023.01.042","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T05:55:04Z","timestamp":1686894904000},"page":"1378-1387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Existing and Developing Preclinical Models for Neurofibromatosis Type 1\u2212Related Cutaneous Neurofibromas"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7874-5585","authenticated-orcid":false,"given":"Verena","family":"Staedtke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-6770","authenticated-orcid":false,"given":"Piotr","family":"Topilko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-5382","authenticated-orcid":false,"given":"Lu Q.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-2366","authenticated-orcid":false,"given":"Kevin","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3183-0491","authenticated-orcid":false,"given":"David A.","family":"Largaespada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-450X","authenticated-orcid":false,"given":"Ross L.","family":"Cagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-6730","authenticated-orcid":false,"given":"Matthew R.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-5295","authenticated-orcid":false,"given":"Anat","family":"Stemmer-Rachamimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-0993","authenticated-orcid":false,"given":"Jaishri O.","family":"Blakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-8631","authenticated-orcid":false,"given":"Steven D.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0494-2946","authenticated-orcid":false,"given":"Ina","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-7047","authenticated-orcid":false,"given":"Carlos G.","family":"Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-8316","authenticated-orcid":false,"given":"Sang Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-9857","authenticated-orcid":false,"given":"Eduard","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.01.042_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","article-title":"Genetic and transcriptional evolution alters cancer cell line drug response","volume":"560","author":"Ben-David","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.01.042_bib2","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3390\/cells9112365","article-title":"Neurofibromin structure, functions and regulation","volume":"9","author":"Bergoug","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jid.2023.01.042_bib3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.0000000000005788","article-title":"The biology of cutaneous neurofibromas: consensus recommendations for setting research priorities","volume":"91","author":"Brosseau","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2023.01.042_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-020-01103-4","article-title":"Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing","volume":"9","author":"Brosseau","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jid.2023.01.042_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcn.2011.08.008","article-title":"Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP\/PKA\/ROCK-dependent manner","volume":"49","author":"Brown","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jid.2023.01.042_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.stemcr.2019.01.001","article-title":"Reprogramming captures the genetic and tumorigenic properties of neurofibromatosis Type 1 plexiform neurofibromas","volume":"12","author":"Carri\u00f3","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jid.2023.01.042_bib7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4252\/wjsc.v11.i12.1065","article-title":"Three-dimensional cell culture systems as an in\u00a0vitro platform for cancer and stem cell modeling","volume":"11","author":"Chaicharoenaudomrung","year":"2019","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.jid.2023.01.042_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/2159-8290.CD-18-0151","article-title":"Spatiotemporal loss of NF1 in Schwann cell lineage leads to different types of cutaneous neurofibroma susceptible to modification by the hippo pathway","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2023.01.042_bib9","doi-asserted-by":"crossref","first-page":"8949","DOI":"10.1523\/JNEUROSCI.23-26-08949.2003","article-title":"The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes","volume":"23","author":"Dasgupta","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jid.2023.01.042_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41523-018-0080-8","article-title":"NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer","volume":"4","author":"Dischinger","year":"2018","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.jid.2023.01.042_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jid.2023.01.042_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.106","article-title":"Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived Schwann cells","volume":"5","author":"Ferrer","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.jid.2023.01.042_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.276.5313.795","article-title":"Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides","volume":"276","author":"Guo","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jid.2023.01.042_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/35002593","article-title":"A\u00a0neurofibromatosis-1-regulated pathway is required for learning in Drosophila","volume":"403","author":"Guo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.01.042_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2023.01.042_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/hmg\/ddl023","article-title":"Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras","volume":"15","author":"Hannan","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2023.01.042_bib17","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3389\/fphar.2019.01484","article-title":"In\u00a0vitro research reproducibility: keeping up high standards","volume":"10","author":"Hirsch","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jid.2023.01.042_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s42003-018-0163-y","article-title":"Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1","volume":"1","author":"Isakson","year":"2018","journal-title":"Commun Biol"},{"key":"10.1016\/j.jid.2023.01.042_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2023.01.042_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is it time to start transitioning from 2D to 3D cell culture?","volume":"7","author":"Jensen","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jid.2023.01.042_bib21","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2023.01.042_bib22","first-page":"910","article-title":"2D and 3D cell cultures - a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jid.2023.01.042_bib23","series-title":"Neurofibromatoses","first-page":"103","author":"Kaufmann","year":"2008"},{"issue":"299(Pt B):","key":"10.1016\/j.jid.2023.01.042_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2017.10.012","article-title":"Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening","author":"Kraniak","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jid.2023.01.042_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1523\/JNEUROSCI.3370-06.2007","article-title":"Phosphatidylinositol 3-kinase and Akt nonautonomously promote perineurial glial growth in Drosophila peripheral nerves","volume":"27","author":"Lavery","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jid.2023.01.042_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.stem.2009.03.017","article-title":"Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas","volume":"4","author":"Le","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jid.2023.01.042_bib26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1523\/JNEUROSCI.15-02-01329.1995","article-title":"The influence of heregulins on human Schwann cell proliferation","volume":"15","author":"Levi","year":"1995","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jid.2023.01.042_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/labinvest.2016.88","article-title":"Immortalization of human normal and NF1 neurofibroma Schwann cells","volume":"96","author":"Li","year":"2016","journal-title":"Lab Invest"},{"key":"10.1016\/j.jid.2023.01.042_bib28","doi-asserted-by":"crossref","first-page":"61500","DOI":"10.18632\/oncotarget.11133","article-title":"The role of nerve microenvironment for neurofibroma development","volume":"7","author":"Liao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2023.01.042_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/aja.1002040411","article-title":"Differential effects of retinoic acid and a retinoid antagonist on the spatial distribution of the homeoprotein Hoxb-7 in vertebrate embryos","volume":"204","author":"L\u00f3pez","year":"1995","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jid.2023.01.042_bib30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jid.2023.01.041","article-title":"Target product profile for cutaneous neurofibromas: clinical trials to prevent, arrest, or regress cutaneous neurofibromas","volume":"143","author":"Ly","year":"2023","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.jid.2023.01.042_bib31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.20389","article-title":"Comprehensive NF1 screening on cultured Schwann cells from neurofibromas","volume":"27","author":"Maertens","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jid.2023.01.042_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/519562","article-title":"Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1","volume":"81","author":"Maertens","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2023.01.042_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110385","article-title":"Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas","volume":"38","author":"Mazuelas","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2023.01.042_bib56","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bcp.2013.08.006","article-title":"Animal models of human disease: challenges in enabling translation","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jid.2023.01.042_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139807","article-title":"Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins","volume":"131","author":"Mo","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2023.01.042_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)63992-2","article-title":"Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells","volume":"158","author":"Muir","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2023.01.042_bib36","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1212\/WNL.0000000000005792","article-title":"Cutaneous neurofibromas: current clinical and pathologic issues","volume":"91","author":"Ortonne","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2023.01.042_bib37","first-page":"vdab020","article-title":"Selumetinib normalizes Ras\/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in\u00a0vivo","volume":"3","author":"Osum","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.jid.2023.01.042_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11010-017-3227-2","article-title":"The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1\u00a0+\/- or NF1 -\/- genotype derived from human cutaneous neurofibromas","volume":"444","author":"Pennanen","year":"2018","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jid.2023.01.042_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/2159-8290.CD-18-0156","article-title":"Cellular origin, tumor progression, and pathogenic mechanisms of cutaneous neurofibromas revealed by mice with Nf1 knockout in boundary cap cells","volume":"9","author":"Radomska","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2023.01.042_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.conb.2017.11.003","article-title":"Boundary cap cells in development and disease","volume":"47","author":"Radomska","year":"2017","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.jid.2023.01.042_bib41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1097-4547(20000901)61:5<524::AID-JNR7>3.0.CO;2-Z","article-title":"Long-term culture and characterization of human neurofibroma-derived Schwann cells","volume":"61","author":"Rosenbaum","year":"2000","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.jid.2023.01.042_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.721045","article-title":"Assessment of mosaicism and detection of cryptic alleles in CRISPR\/Cas9-engineered neurofibromatosis Type 1 and TP53 mutant porcine models reveals overlooked challenges in precision modeling of human diseases","volume":"12","author":"Rubinstein","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jid.2023.01.042_bib43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm0195-80","article-title":"Purification and expansion of human Schwann cells in\u00a0vitro","volume":"1","author":"Rutkowski","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2023.01.042_bib44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/hmg\/9.7.1059","article-title":"Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1","volume":"9","author":"Rutkowski","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2023.01.042_bib45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/90148","article-title":"Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas [published correction appears in Nat Genet 2001;29:100]","volume":"28","author":"Serra","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2023.01.042_bib46","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2023.01.042_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing [published correction appears in vet Pathol 2012;49:738","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jid.2023.01.042_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ejhg.2011.207","article-title":"Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas","volume":"20","author":"Thomas","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jid.2023.01.042_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nn792","article-title":"Neurofibromin regulates G protein-stimulated adenylyl cyclase activity","volume":"5","author":"Tong","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jid.2023.01.042_bib50","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1038\/s41598-020-61251-4","article-title":"Longitudinal phenotype development in a minipig model of neurofibromatosis type 1","volume":"10","author":"Uthoff","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2023.01.042_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<117::AID-GCC1>3.0.CO;2-H","article-title":"Culture of cytogenetically abnormal Schwann cells from benign and malignant NF1 tumors","volume":"27","author":"Wallace","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jid.2023.01.042_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120402","article-title":"A\u00a0porcine model of neurofibromatosis type 1 that mimics the human disease","volume":"3","author":"White","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2023.01.042_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jid.2023.01.042_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2007.12.027","article-title":"Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in Desert hedgehog-expressing cells","volume":"13","author":"Wu","year":"2008","journal-title":"Cancer Cell"}],"updated-by":[{"DOI":"10.1016\/j.jid.2023.08.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000}}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23019620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23019620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T23:33:05Z","timestamp":1722555185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23019620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022202X23019620"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.01.042","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jid.2023.08.005","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Existing and Developing Preclinical Models for Neurofibromatosis Type 1\u2212Related Cutaneous Neurofibromas","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}